Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Large Growth · Wasatch

Wasatch Ultra Growth Fund Institutional Class Shares (WGMCX)

Ticker WGMCX · Since 2020-01-31 · · Holdings as of Jun 30, 2026

Expense ratio
1.05%$105/yr per $10k
5-yr return
−4.3%annualized
1-yr return
−2.7%as of Dec 2025
Net assets
$461.4Mall share classes
Holdings
57

Bottom line

Is WGMCX a good fund? The bottom line

WGMCX is the Institutional Class share class of Wasatch Ultra Growth Fund, an actively managed large growth mutual fund from Wasatch.

Annual fees run 1.05% — about $105 a year on every $10,000 invested, more expensive than 68% of large growth funds we track.

It returned −2.7% over one year, −4.3% a year over five years (as of Dec 31, 2025, per its prospectus).

With $461 million in net assets and 57 holdings, its largest position is HealthEquity Inc (4.4%) and the top 10 make up 31.4% of the portfolio.

What stands out

  • No front-end sales load

What to watch

  • 5-year return in the bottom quarter of its category

Updated Nov 19, 2026

What WGMCX invests in

The Funds primary investment objective is long-term growth of capital.

The Fund invests primarily in smaller high growth companies. Under normal market conditions, we will invest the Funds net assets primarily in the equity securities, typically common stock, of smaller companies that we believe have the potential for rapid growth in earnings per share. These companies are typically relatively small, with minimum market capitalizations of $100 million and up to a maximum market capitalization at the time of purchase of $5 billion or the market capitalization of the largest company in the Russell 2000 Growth Index as of its most recent reconstitution date, whichever is greater. The Russell 2000 Growth Index reconstitution date is typically each year on or around July 1. As of the 2025 reconstitution date, the market capitalization of companies included in the Russell 2000 Growth Index ranged from $ 61 million to $ 16.033 billion. The market capitalizations…

From the fund's prospectus (filed Jan 28, 2026).

WGMCX performance

Average annual total returns
1 yr5 yr10 yr
WGMCX−2.7%−4.3%—
Large Growth median+15.2%+11.0%+14.2%

Source: Fund prospectus, as of Dec 31, 2025

Full WGMCX performance history →

What WGMCX costs

On a $10,000 investment, WGMCX's 1.05% expense ratio costs about $105 a year. The prospectus estimates $1,314 in total costs over 10 years (assuming 5% annual returns). The median large growth fund charges 0.87%.

See the full WGMCX fee table →

WGMCX top 10 holdings

#Holding% of fund
1HealthEquity Inc4.39%
2Casella Waste Systems Inc3.70%
3Freshpet Inc3.62%
4JFrog Ltd3.07%
5RBC Bearings Inc2.99%
6PDF Solutions Inc2.97%
7Loar Holdings Inc2.93%
8Adaptive Biotechnologies Corp2.61%
9Johnnie O Holdings, Inc2.58%
10Viking Therapeutics Inc2.54%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 31.4% of the fund. See all top 25 holdings and asset mix →

Alternatives to WGMCX

More funds like WGMCX →

WGMCX FAQ

What is the expense ratio of WGMCX?
WGMCX's expense ratio is 1.05%, which works out to about $105 a year for every $10,000 invested. The prospectus estimates total costs of $1,314 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is WGMCX a good investment?
It depends on your goals, but the data points to: no front-end sales load; 5-year return in the bottom quarter of its category. This is general information, not personalized advice.
What does WGMCX hold?
WGMCX's largest holdings are HealthEquity Inc (4.4%), Casella Waste Systems Inc (3.7%), Freshpet Inc (3.6%), JFrog Ltd (3.1%), RBC Bearings Inc (3.0%). It holds 57 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
What is WGMCX's 5-year return?
WGMCX returned −4.3% a year over the five years ending Dec 31, 2025. Past performance does not guarantee future results.
Does WGMCX have a sales load?
No. WGMCX has no front-end sales charge.
Who manages WGMCX?
WGMCX is offered by Wasatch through Wasatch Funds Trust.